North East patients are among the first in the UK to trial Lutetium (177Lu) rhPSMA-10.1, a new targeted treatment for ...
A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, completely eradicating tumors in certain preclinical models. Targeting the ...
Blue Earth Therapeutics today announced that the first patients in the UK have been administered with the investigational radiopharmaceutical therapy Lutetium (177Lu) rhPSMA-10.1 Injection in an ...
MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix') today announces that the Chinese National Medical Products ...
Researchers in Japan are developing world-leading expertise in making and using the alpha particle emitter, astatine-211 (211 At), which has potential for use as a strong radionuclide therapy for ...
AZoLifeSciences on MSN
Engineered human skin acts as a living biosensor for inflammation
Implanted living skin-based biosensors offer a breakthrough in inflammation tracking, providing real-time biomarker ...
The three-year, ACGME-accredited nuclear medicine residency offers training in diagnostic nuclear medicine imaging, non-imaging procedures and a wide range of nuclear medicine therapeutic procedures.
The National Center for Electron Beam Research and National Nuclear Security Administration will pilot eBeam in medical ...
North Korean leader Kim Jong Un says his country will unveil plans to further bolster its nuclear program at the upcoming ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results